Autolomous

Autolomous is a UK-based startup focused on providing digital solutions for Cell and Gene Therapy Manufacturing. Founded in 2019 by experts in the field, the company aims to offer scalable and agile software solutions for the Cell and Gene Therapy sector. Their flagship product, AutoloMATE-solution platform, encompasses various software solutions including electronic Batch Manufacturing Records (eBMR), patient blood collection scheduling, traceability enhancement, regulatory compliance support, and drug product release acceleration. The company's focus on automation and risk reduction aligns with the industry's need for precision and efficiency. Their recent grant investment from Innovate UK on 12 June 2023 validates their potential for growth and innovation in the biotechnology, healthcare, information technology, manufacturing, and pharmaceutical sectors. Autolomous offers an exciting opportunity for forward-thinking individuals to contribute to a meaningful and value-driven company. Their pragmatic approach to digital solutions positions them as a promising entity in the evolving landscape of Cell and Gene Therapy.